These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27425792)

  • 21. Editorial Commentary: Resurrecting a Live Oral Cholera Vaccine.
    Harris JB
    Clin Infect Dis; 2016 Jun; 62(11):1336-7. PubMed ID: 27001802
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on CVD 103-HgR single-dose, live oral cholera vaccine.
    McCarty J; Bedell L; De Lame PA; Cassie D; Lock M; Bennett S; Haney D
    Expert Rev Vaccines; 2022 Jan; 21(1):9-23. PubMed ID: 34775892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Kaper JB; Levine MM
    J Infect Dis; 1992 Oct; 166(4):837-41. PubMed ID: 1527420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.
    Chen WH; Greenberg RN; Pasetti MF; Livio S; Lock M; Gurwith M; Levine MM
    Clin Vaccine Immunol; 2014 Jan; 21(1):66-73. PubMed ID: 24173028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
    Chowdhury MI; Sheikh A; Qadri F
    Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of cholera and rise of novel mucosal vaccine.
    Yamamoto T
    Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
    Cookson ST; Stamboulian D; Demonte J; Quero L; Martinez de Arquiza C; Aleman A; Lepetic A; Levine MM
    Int J Epidemiol; 1997 Feb; 26(1):212-9. PubMed ID: 9126522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
    Lagos R; Avendaño A; Prado V; Horwitz I; Wasserman S; Losonsky G; Cryz S; Kaper JB; Levine MM
    Infect Immun; 1995 Feb; 63(2):707-9. PubMed ID: 7822046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
    Taylor DN; Sanchez JL; Castro JM; Lebron C; Parrado CM; Johnson DE; Tacket CO; Losonsky GA; Wasserman SS; Levine MM; Cryz SJ
    Infect Immun; 1999 Apr; 67(4):2030-4. PubMed ID: 10085055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral vaccines against cholera: lessons from Vietnam and elsewhere.
    Levine MM
    Lancet; 1997 Jan; 349(9047):220-1. PubMed ID: 9014902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An overview of Vaxchora
    Saluja T; Mogasale VV; Excler JL; Kim JH; Mogasale V
    Hum Vaccin Immunother; 2020; 16(1):42-50. PubMed ID: 31339792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peru-15 (Choleragarde(®)), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand.
    Ratanasuwan W; Kim YH; Sah BK; Suwanagool S; Kim DR; Anekthananon A; Lopez AL; Techasathit W; Grahek SL; Clemens JD; Wierzba TF
    Vaccine; 2015 Sep; 33(38):4820-6. PubMed ID: 26241948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home Administration of CVD 103-HgR: A Live Attenuated Oral Cholera Vaccine.
    Duffin RP; Delbuono M; Chew L; Johnstone J; Niedan V; Schwarz P; Shabram P; Patel AA
    Am J Trop Med Hyg; 2021 Mar; 104(4):1232-1240. PubMed ID: 33646977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral vaccines for cholera control.
    Chaturvedi S; Chaturvedi S
    Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.
    Richie EE; Punjabi NH; Sidharta YY; Peetosutan KK; Sukandar MM; Wasserman SS; Lesmana MM; Wangsasaputra FF; Pandam SS; Levine MM; O'Hanley PP; Cryz SJ; Simanjuntak CH
    Vaccine; 2000 May; 18(22):2399-410. PubMed ID: 10738097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
    Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand.
    Su-Arehawaratana P; Singharaj P; Taylor DN; Hoge C; Trofa A; Kuvanont K; Migasena S; Pitisuttitham P; Lim YL; Losonsky G
    J Infect Dis; 1992 Jun; 165(6):1042-8. PubMed ID: 1583321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.